Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer

[1]  C. Hammer,et al.  Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion , 2021, Nature Reviews Cancer.

[2]  Katie M. Campbell,et al.  Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction , 2020, Cell.

[3]  Ying S. Ting,et al.  A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer , 2020, Cell.

[4]  H. Rammensee,et al.  Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies* , 2020, Molecular & Cellular Proteomics.

[5]  Malachi Griffith,et al.  pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens , 2020, Cancer Immunology Research.

[6]  Brian J. Stevenson,et al.  Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment , 2019, Journal of Immunotherapy for Cancer.

[7]  Martin L. Miller,et al.  UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma , 2019, Cell.

[8]  G. Coukos,et al.  Mass spectrometry–driven exploration reveals nuances of neoepitope-driven tumor rejection , 2019, JCI insight.

[9]  Lauren E. Stopfer,et al.  Rebalancing Protein Homeostasis Enhances Tumor Antigen Presentation , 2019, Clinical Cancer Research.

[10]  M. Merad,et al.  β-catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma. , 2019, Cancer discovery.

[11]  Ahmet Zehir,et al.  Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response , 2019, Science.

[12]  E. Wherry,et al.  CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer. , 2019, Annual review of immunology.

[13]  J. Sidney,et al.  New epitopes in ovalbumin provide insights for cancer neoepitopes. , 2019, JCI insight.

[14]  F. Hodi,et al.  Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade , 2019, Nature Immunology.

[15]  Aviv Regev,et al.  Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD‐1−CD8+ Tumor‐Infiltrating T Cells , 2019, Immunity.

[16]  C. Brennan,et al.  Tumor mutational load predicts survival after immunotherapy across multiple cancer types , 2019, Nature Genetics.

[17]  Daniel E. Speiser,et al.  Intratumoral Tcf1+PD‐1+CD8+ T Cells with Stem‐like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy , 2019, Immunity.

[18]  H. Algül,et al.  Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options , 2018, Front. Immunol..

[19]  Christopher T. Saunders,et al.  Strelka2: fast and accurate calling of germline and somatic variants , 2018, Nature Methods.

[20]  J. Marioni,et al.  T cell cytolytic capacity is independent of initial stimulation strength , 2018, Nature Immunology.

[21]  A. Halpern,et al.  Strelka2: fast and accurate calling of germline and somatic variants , 2018, Nature Methods.

[22]  D. Littman,et al.  Critical Role for the Microbiota in CX3CR1+ Intestinal Mononuclear Phagocyte Regulation of Intestinal T Cell Responses , 2018, Immunity.

[23]  J. Marioni,et al.  T cell cytolytic capacity is independent of initial stimulation strength , 2018, Nature Immunology.

[24]  M. Fehlings,et al.  Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates , 2018, Nature.

[25]  W. Held,et al.  Suppression of Tcf1 by Inflammatory Cytokines Facilitates Effector CD8 T Cell Differentiation. , 2018, Cell reports.

[26]  Adam Akkad,et al.  Colonoscopy-based colorectal cancer modeling in mice with CRISPR–Cas9 genome editing and organoid transplantation , 2018, Nature Protocols.

[27]  F. Nicolantonio,et al.  Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth , 2017, Nature.

[28]  M. Nielsen,et al.  NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data , 2017, The Journal of Immunology.

[29]  Ludmila V. Danilova,et al.  Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade , 2017, Science.

[30]  Morten Nielsen,et al.  NetMHCpan 4.0: Improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data , 2017, bioRxiv.

[31]  J. Nemunaitis,et al.  Faculty Opinions recommendation of Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity. , 2017 .

[32]  Donavan T. Cheng,et al.  Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients , 2017, Nature Medicine.

[33]  Antonina V. Kurtova,et al.  A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer , 2017, Nature.

[34]  Francisco J. Sánchez-Rivera,et al.  In vivo genome editing and organoid transplantation models of colorectal cancer , 2017, Nature Biotechnology.

[35]  A. Bhandoola,et al.  CD8+ T Lymphocyte Self-Renewal during Effector Cell Determination. , 2016, Cell reports.

[36]  W. Haining,et al.  Immediate Dysfunction of Vaccine-Elicited CD8+ T Cells Primed in the Absence of CD4+ T Cells , 2016, The Journal of Immunology.

[37]  R. Vonderheide,et al.  CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer. , 2016, Cell reports.

[38]  Timothy J. Yeatman,et al.  A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC , 2016, Nature Communications.

[39]  Nicolai J. Birkbak,et al.  Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade , 2016, Science.

[40]  Z. Trajanoski,et al.  Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability. , 2016, Immunity.

[41]  F. Cunningham,et al.  The Ensembl Variant Effect Predictor , 2016, bioRxiv.

[42]  Morten Nielsen,et al.  Gapped sequence alignment using artificial neural networks: application to the MHC class I system , 2016, Bioinform..

[43]  J. Frick,et al.  Molecular Mechanisms of Induction of Tolerant and Tolerogenic Intestinal Dendritic Cells in Mice , 2016, Journal of immunology research.

[44]  K. Rajewsky,et al.  Efficient generation of Rosa26 knock-in mice using CRISPR/Cas9 in C57BL/6 zygotes , 2016, BMC Biotechnology.

[45]  A. Butte,et al.  Systematic pan-cancer analysis of tumour purity , 2015, Nature Communications.

[46]  Hans Clevers,et al.  Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer , 2015, Cell.

[47]  T. Gajewski,et al.  Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity , 2015, Nature.

[48]  B. Igyártó,et al.  Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance , 2015, Cell.

[49]  Hans Clevers,et al.  Sequential cancer mutations in cultured human intestinal stem cells , 2015, Nature.

[50]  Ben Lehner,et al.  Differential DNA mismatch repair underlies mutation rate variation across the human genome , 2015, Nature.

[51]  Maxim N. Artyomov,et al.  Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens , 2014, Nature.

[52]  Francisco J. Sánchez-Rivera,et al.  Rapid modeling of cooperating genetic events in cancer through somatic genome editing , 2014, Nature.

[53]  Benjamin Schubert,et al.  OptiType: precision HLA typing from next-generation sequencing data , 2014, Bioinform..

[54]  M. Schatz,et al.  Accurate detection of de novo and transmitted indels within exome-capture data using micro-assembly , 2014, Nature Methods.

[55]  Neville E. Sanjana,et al.  Improved vectors and genome-wide libraries for CRISPR screening , 2014, Nature Methods.

[56]  Gregory L. Szeto,et al.  Structure-based programming of lymph-node targeting in molecular vaccines , 2014, Nature.

[57]  Hiroyuki Miyoshi,et al.  In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture , 2013, Nature Protocols.

[58]  John Sidney,et al.  Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. , 2013, Cancer cell.

[59]  Knut Reinert,et al.  RazerS 3: Faster, fully sensitive read mapping , 2012, Bioinform..

[60]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[61]  A. McKenna,et al.  Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.

[62]  T. Jacks,et al.  Expression of tumour-specific antigens underlies cancer immunoediting , 2011, Nature.

[63]  David J. Rawlings,et al.  Tracking genome engineering outcome at individual DNA breakpoints , 2011, Nature Methods.

[64]  E. Wherry.  T cell exhaustion , 2011, Nature Immunology.

[65]  T. Jacks,et al.  Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression. , 2011, Cancer cell.

[66]  G. Splitter,et al.  Antigen specific killing assay using CFSE labeled target cells. , 2010, Journal of visualized experiments : JoVE.

[67]  J. Harty,et al.  Differentiation and persistence of memory CD8(+) T cells depend on T cell factor 1. , 2010, Immunity.

[68]  Clemencia Pinilla,et al.  Derivation of an amino acid similarity matrix for peptide:MHC binding and its application as a Bayesian prior , 2009, BMC Bioinformatics.

[69]  R. Offringa,et al.  Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100. , 2009, Cancer research.

[70]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[71]  T. Jacks,et al.  Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase , 2009, Nature Protocols.

[72]  A. Strasser,et al.  The molecular signature of CD8+ T cells undergoing deletional tolerance. , 2009, Blood.

[73]  E. Unanue,et al.  Batf3 Deficiency Reveals a Critical Role for CD8α+ Dendritic Cells in Cytotoxic T Cell Immunity , 2008, Science.

[74]  Jennifer J. Lund,et al.  Adenomatous Polyposis Coli (APC) Is Required for Normal Development of Skin and Thymus , 2006, PLoS genetics.

[75]  Alessandro Sette,et al.  Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method , 2005, BMC Bioinformatics.

[76]  Mark M Davis,et al.  How T cells 'see' antigen , 2005, Nature Immunology.

[77]  M. Nishimura,et al.  Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells. , 2002, Immunity.

[78]  K. Rajewsky,et al.  Homeostasis of Peripheral B Cells in the Absence of B Cell Influx from the Bone Marrow , 2001, The Journal of experimental medicine.

[79]  T. Jacks,et al.  Somatic activation of the K-ras oncogene causes early onset lung cancer in mice , 2001, Nature.

[80]  A. Berns,et al.  Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. , 2000, Genes & development.

[81]  E. Wherry,et al.  The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained. , 1999, Journal of immunology.

[82]  A. Lanzavecchia,et al.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.

[83]  Kristin A. Hogquist,et al.  T cell receptor antagonist peptides induce positive selection , 1994, Cell.

[84]  K. Kawai.  γδ T Cells , 2016 .

[85]  Trevor J Pugh,et al.  Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .

[86]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .